IBAB Ion Beam Applications SA

IBA is looking for 100 new collaborators in Belgium by June 2023

IBA is looking for 100 new collaborators in Belgium by June 2023

Louvain-la-Neuve, Belgium, 14 March 2023  - (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology wants to hire 100 new employees during the first half of 2023. Among the actions undertaken to achieve this goal, the company is organizing a special recruitment evening, "Meet & Join IBA", in Louvain-la-Neuve on March 28. Interested parties are invited to register on the Forem website.

For more than 35 years, IBA has been designing, producing, and marketing innovative solutions for the diagnosis and treatment of cancer and other serious diseases, as well as industrial applications in the field of sterilization. As a world leader in particle accelerator technology, with an order backlog of more than EUR 1 billion, the company supplies thousands of hospitals and healthcare companies around the world with its accelerators, medical devices and applications for proton therapy, nuclear medicine, sterilization, and dosimetry. 

IBA, which currently employs more than 1,800 people (including 900 in Belgium) in more than 40 countries, wants to recruit 100 additional employees in Louvain-la-Neuve by June 2023.

Talents sought? IT, scientific, technical and management profiles

Many profiles are sought to meet the growth of the company's various activities: software developers, R&D project managers, automation engineers, data engineers, buyers, fitters, qualification & validation engineers, electromechanical engineers, hardware engineers, etc.

Special recruitment evening on March 28 in Louvain-la-Neuve at IBA

Candidates interested in the offers are invited to discover the company and the jobs during the "Meet & Join IBA" event organized by IBA in collaboration with Forem. This special evening will be an opportunity for candidates to meet their future colleagues while immersing themselves in the unique environment and culture of this international Walloon company. To participate, simply consult IBA's job offers on the Forem website, check the required skills, and fill in the registration form corresponding to the selected position(s).  Registration is open until March 26 and is mandatory.

“Meet & Join IBA” with the collaboration of Forem

Tuesday, March 28 from 5.30 to 9.00 PM

Chemin du Cyclotron 3, 1348 Ottignies-Louvain-la-Neuve

Program:

  • 5.30 > 6 PM: Reception
  • 6 > 6.20 PM: IBA Presentation 
  • 6.20 > 6.30 PM: Question & answer session
  • 6.30 > 7.15 PM: Guided tour of the assembly hall
  • 7.15 > 9 PM: Drink & networking

News and inscriptions:

*** Ends ***

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

For further information, please contact:

IBA

Olivier Lechien

Corporate Communication Director



Attachment



EN
14/03/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ackermans & van Haaren: Expect buoyed contribution from Private Banking. ASR: 1H: strong solvency, buyouts at 12% IRR. Deceuninck: Weak set of results, as expected following the change in CEO. EVS: Very weak 1H25, but guidance unchanged; convincing bolt-on deal in the US. IBA: IBA to install one P1 system at university campus in Heidelberg, Germany. NEPI Rockcastle: Robust performance, small upward revision to guidance

Guy Sips ... (+7)
  • Guy Sips
  • Kristof Samoy
  • Livio Luyten
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi
 PRESS RELEASE

Heidelberg University Hospital expands its particle therapy program wi...

Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution Louvain-La-Neuve, Belgium, August 20, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a contract to install a Proteus®ONE1 compact proton therapy solution to be located on the University campus in Heidelberg, Germany. The first payment ...

 PRESS RELEASE

L'hôpital universitaire de Heidelberg élargit son programme de thérapi...

L'hôpital universitaire de Heidelberg élargit son programme de thérapie par particules avec une solution Proteus®ONE Louvain-la-Neuve, Belgique, le 20 août 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le traitement du cancer, et l'hôpital universitaire de Heidelberg (Universitätsklinikum Heidelberg AöR, UKHD) annoncent aujourd'hui la signature d'un contrat pour l'installation d'une solution compacte de protonthérapie Proteus®ONE1  sur le campus universitaire...

 PRESS RELEASE

IBA Notice of Half Year 2025 Results and Conference Call

IBA Notice of Half Year 2025 Results and Conference Call HY25 results webcast to take place on Thursday, 28 August 2025 at 3pm CEST Louvain-la-Neuve, Belgium, 07 August 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the half year 2025 on Thursday, 28 August 2025 at 7am CEST. Conference Call Information IBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session. The con...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch